Related Experiment Videos
Niacin as a potential AIDS preventive factor
1Tewksbury Hospital, Department of Medicine, MA 01876, USA. docsmurr@massmed.org
Medical Hypotheses
|January 1, 2000
Summary
Human immunodeficiency virus (HIV) infection may cause niacin depletion. Supplementing with niacin, a B vitamin, could potentially serve as an AIDS preventive factor, especially for those unable to afford antiretroviral therapy.
Area of Science:
- Biochemistry
- Immunology
- Nutritional Science
Background:
- Patients with Acquired Immunodeficiency Syndrome (AIDS) exhibit findings consistent with niacin depletion.
- Clinical and laboratory data suggest potential benefits of niacin in managing Human Immunodeficiency Virus (HIV) infection.
- HIV infection leads to significant metabolic disruption due to high viral production rates.
Purpose of the Study:
- To hypothesize that HIV infection induces niacin depletion.
- To propose therapeutic niacin as a potential secondary AIDS preventive factor.
- To explore cost-effective strategies for managing metabolic disruption in HIV-infected individuals.
Main Methods:
- Review of existing clinical and laboratory data on niacin depletion in AIDS patients.
- Hypothetical model linking HIV infection, niacin depletion, and AIDS prevention.
- Literature review on niacin's role as a 'pellagra preventive factor'.
Main Results:
- Niacin depletion is a recognized issue in AIDS patients.
- Niacin has demonstrated potential benefits in HIV infection contexts.
- Therapeutic niacin is proposed as an accessible secondary AIDS preventive strategy.
Conclusions:
- HIV infection is hypothesized to cause niacin depletion.
- Niacin supplementation may act as an AIDS preventive factor.
- Niacin offers a potential complementary strategy to antiretroviral therapy for HIV management.